Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants

Journal of Virological Methods

Volumn 83, Issue 1-2, 1999, Pages 181-187

  Jardi, Rosendo ^a   Buti, Maria ^a   Rodriguez Frias, Francisco ^a   Cotrina, Montserrat ^a   Costa, Xose ^a   Pascual, Carles ^a   Esteban, Rafael ^a   Guardia, Jaime ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

HBV; Lamivudine; PCR RFLP; Polymerase gene; Sequence analysis; YMDD variants

Indexed keywords

LAMIVUDINE;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; GENOTYPE; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS GENE;

ANTIVIRAL AGENTS; BASE SEQUENCE; DNA PRIMERS; DNA, VIRAL; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MICROBIAL; GENES, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TIME FACTORS; VARIATION (GENETICS); VIROLOGY;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032701907     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00125-1     Document Type: Article

References (16)

1. Allen M.I., Deslauriers M., Andrews C.W., Tipples G.A., Walters K.A., Tyrrel D.L.J., Brown N. Identification and characterisation of mutations in hepatitis B virus resistant to lamivudine. Hepatology. 27:1998;1670-1677.
2. Bartholomeusz A., Schinazi R.F., Locarnini S.A. Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease. Viral Hepat. 4:1998;167-187.
3. Buti M., Jardi R., Cotrina M., Rodriguez F., Esteban R., Guardia J. Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine. J. Hepatol. 28:1998;510-513.
4. Chayama K., Suzuki Y., Kobayashi M., Kobayashi M., Tsubota A., Hashimoto M., Miyano Y., Koike H., Kobayashi M., Koida I. Emergence and takeover of YMDD motif mutant hepatitis B virus during long term lamivudine therapy and re-take-over by wild type after cessation of therapy. Hepatology. 27:1998;1711-1716.
5. Field H.J., Darby G. Pathogenicity in minces of herpes simplex viruses which is resistant to acyclovir in vitro and in vivo. Antimicrob. Agents Chemother. 17:1980;209-216.
6. Hoofnagle J.H. Therapy of viral hepatitis. Digestion. 59:1998;563-578.
7. Ladner S.K., Miller T.J., Otto M.J., King R.W. The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues. Antiviral Chem. Chemother. 9:1998;65-72.
8. Lai C.H.L., Chien R.N., Leung N.W.Y., Chang T.T., Guan R., Tai D.I., Tai D.I., Ng K.Y., Wu P.C., Dent J.C., Barber J., Stephenson S.L., Fraser D. A one year trial of lamivudine for chronic hepatitis. N. Engl. J. Med. 339:1998;61-68.
9. Lindh M., Anderson A.S., Gustal A. Genotypes, nt 1858 variants and geographic origin of hepatitis B virus, large scale analysis using a new genotyping method. J. Infect. Dis. 175:1997;1285-1293.
10. Ling R., Mutimer D., Ahmed M., Boxall E.H., Elias E., Dusheiko G.M., Harrison T. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology. 24:1996;711-713.
11. Melegari M., Scaglioni P.P., Wands J. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology. 27:1998;628-633.
12. Niesters H.G., Honkoop P., Haagsma A.B., Man R.A., Schalm S.W., Osterhaus A.D.M. Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J. Infect. Dis. 177:1998;1382-1385.
13. Repp R., Rhiel S., Heermann K.H., Schaefer S., Keller C., Ndumbe P., Lampert F., Gerlich W.H. Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J. Clin. Microbiol. 31:1993;1095-1102.
14. Rodriguez F., Buti M., Jardi R., Cotrina M., Viladomiu L., Esteban R., Guardia J. Precore mutants and its relation to viral genotypes. Hepatology. 22:1995;1641-1647.
15. Severini A., Liu X.Y., Wilson J.S., Tyrrell D.L.J. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2′, 3′-dideoxy-3′ thiacytidine. Antimicrob. Agents Chemother. 39:1995;1430-1435.
16. Tipples G.A., Fischer M.M., Bain V.G., Kneteman N.M., Tyrrell D.L. Mutation in hepatitis B virus RNA dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology. 24:1998;714-717.